Advances in the diagnosis and treatment of human papillomavirus infections. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Advances in the diagnosis and treatment of human papillomavirus infections.

Clin Obstet Gynecol. 1999 Jun;42(2):206-20. Unique Identifier : AIDSLINE MED/99298980
Sedlacek TV; Allegheny University, Philadelphia, PA 19146, USA.

Abstract: During the past decade, much has been learned about the natural history of HPV. Most infections occur early in one's sexual life. The overwhelming majority of infections are cleared by the host immune system and never present as warts or neoplasia. Certain patient behavior such as smoking, frequent sex with many different partners, other STD infections, especially HIV, and immune-suppressive drugs promote HPV expression and cause persistent infection. Persistent HPV infection is very strongly related to neoplasia. In addition to high-risk HPV types, variant subtypes have been identified that interact with the host immune system to subvert host immunity and encourage viral persistence. New treatment programs rely on drugs that modulate the immune system and disrupt viral persistence. There is a real possibility of HPV vaccines in the future, which may protect the unexposed patient.
Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Cell Transformation, Neoplastic Cervical Intraepithelial Neoplasia/VIROLOGY Cervix Neoplasms/VIROLOGY Condylomata Acuminata/DIAGNOSIS/THERAPY Female Human Incidence *Papillomavirus, Human *Papovaviridae Infections/DIAGNOSIS/EPIDEMIOLOGY/THERAPY Prevalence *Tumor Virus Infections/DIAGNOSIS/EPIDEMIOLOGY/THERAPYKWDjournalarticlereviewreview,tutorialcelltransformation,neoplasticcervicalintraepithelialneoplasia/virologycervixneoplasms/virologycondylomataacuminata/diagnosis/therapyfemalehumanincidenceKWDpapillomavirus,humanKWDpapovaviridaeinfections/diagnosis/epidemiology/therapyprevalenceKWDtumorvirusinfections/diagnosis/epidemiology/therapy
991030
A99A0897

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .